SciSparc shares surge 31.07% premarket after NeuroThera acquires 55% stake in quantum computing bio data company.

SciSparc Ltd. (SPRC) surged 31.07% in premarket trading following news that Neurothera Labs signed a non-binding term sheet to acquire a 55% stake in a quantum computing bio data company under its portfolio. The deal, though non-binding, signals strategic interest in SciSparc’s technology and could enhance its market position in the emerging quantum computing sector. The heightened media sentiment score (2/2) and increased news coverage over the past week further underscore growing investor confidence. This development aligns with the stock’s sharp premarket rally, reflecting optimism around potential collaboration and value creation.